These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34792003)

  • 21. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Overview of Drug Delivery Systems.
    Jain KK
    Methods Mol Biol; 2020; 2059():1-54. PubMed ID: 31435914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions.
    Nhàn NTT; Yamada T; Yamada KH
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DCTPep, the data of cancer therapy peptides.
    Sun X; Liu Y; Ma T; Zhu N; Lao X; Zheng H
    Sci Data; 2024 May; 11(1):541. PubMed ID: 38796630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zebrafish as a model to evaluate peptide-related cancer therapies.
    Shull AY; Hu CA; Teng Y
    Amino Acids; 2017 Dec; 49(12):1907-1913. PubMed ID: 28316026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
    Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
    J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor-mediated tumor targeting based on peptide hormones.
    Mezo G; Manea M
    Expert Opin Drug Deliv; 2010 Jan; 7(1):79-96. PubMed ID: 19947889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery.
    Li ZJ; Cho CH
    J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S1. PubMed ID: 23046982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel delivery systems for improving the clinical use of peptides.
    Kovalainen M; Mönkäre J; Riikonen J; Pesonen U; Vlasova M; Salonen J; Lehto VP; Järvinen K; Herzig KH
    Pharmacol Rev; 2015 Jul; 67(3):541-61. PubMed ID: 26023145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide drugs to target G protein-coupled receptors.
    Bellmann-Sickert K; Beck-Sickinger AG
    Trends Pharmacol Sci; 2010 Sep; 31(9):434-41. PubMed ID: 20655603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Advances in Peptide-Based Approaches for Cancer Treatment.
    Conibear AC; Schmid A; Kamalov M; Becker CFW; Bello C
    Curr Med Chem; 2020; 27(8):1174-1205. PubMed ID: 29173146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer-targeted delivery systems based on peptides.
    Chatzisideri T; Leonidis G; Sarli V
    Future Med Chem; 2018 Sep; 10(18):2201-2226. PubMed ID: 30043641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laminin-derived peptides: Applications in drug delivery systems for targeting.
    Negishi Y; Nomizu M
    Pharmacol Ther; 2019 Oct; 202():91-97. PubMed ID: 31158392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based optimization of GRP78-binding peptides that enhances efficacy in cancer imaging and therapy.
    Wang SH; Lee AC; Chen IJ; Chang NC; Wu HC; Yu HM; Chang YJ; Lee TW; Yu JC; Yu AL; Yu J
    Biomaterials; 2016 Jul; 94():31-44. PubMed ID: 27088408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in Anti-cancer Protein/Peptide Delivery.
    Liu X; Wu F; Ji Y; Yin L
    Bioconjug Chem; 2019 Feb; 30(2):305-324. PubMed ID: 30428665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered Cell-Penetrating Peptides for Mitochondrion-Targeted Drug Delivery in Cancer Therapy.
    Xiao Q; Dong X; Yang F; Zhou S; Xiang M; Lou L; Yao SQ; Gao L
    Chemistry; 2021 Oct; 27(59):14721-14729. PubMed ID: 34436802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Peptide Therapeutic Approaches for Cancer Treatment.
    Li CM; Haratipour P; Lingeman RG; Perry JJP; Gu L; Hickey RJ; Malkas LH
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of membrane-active peptide therapeutics in oncology.
    Chen CH; Zan B; Ulmschneider JP; Wimley WC; Lu TK; Ulmschneider MB; Zhou L
    J Pept Sci; 2023 Aug; 29(8):e3482. PubMed ID: 36739581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.